Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IBD: measuring what counts-safety of IBD medications in pregnancy.

Literature DB >> 21304477

IBD: measuring what counts-safety of IBD medications in pregnancy.

Abstract

Uncertainty about the risks of medications for IBD during pregnancy is a challenge for clinicians and patients. a recent prospective cohort study suggests that women under medical care for their disease have few adverse events.

Entities: Species

Mesh：

Substances：

Year: 2011 PMID： 21304477 DOI： 10.1038/nrgastro.2011.18

Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802

10 in total

1. Perinatal outcomes in inflammatory bowel disease.

Authors: M C Bush; S Patel; R H Lapinski; J L Stone
Journal: J Matern Fetal Neonatal Med Date: 2004-04

2. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.

Authors: Deepa Reddy; Seamus J Murphy; Sunanda V Kane; Daniel H Present; Asher A Kornbluth
Journal: Am J Gastroenterol Date: 2008-04-16 Impact factor: 10.864

3. A controlled double blind study of azathioprine in the management of Crohn's disease.

Authors: S Candy; J Wright; M Gerber; G Adams; M Gerig; R Goodman
Journal: Gut Date: 1995-11 Impact factor: 23.059

4. [Prevalence and prenatal diagnosis of congenital malformations in the Parisian population: twenty years of surveillance by the Paris Registry of congenital malformations].

Authors: C De Vigan; B Khoshnood; A Lhomme; V Vodovar; J Goujard; F Goffinet
Journal: J Gynecol Obstet Biol Reprod (Paris) Date: 2005-02

5. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Authors: A B Hawthorne; R F Logan; C J Hawkey; P N Foster; A T Axon; E T Swarbrick; B B Scott; J E Lennard-Jones
Journal: BMJ Date: 1992-07-04

6. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Authors: Jessica Coelho; Laurent Beaugerie; Jean Frédéric Colombel; Xavier Hébuterne; Eric Lerebours; Marc Lémann; Philippe Baumer; Jacques Cosnes; Arnaud Bourreille; Jean Pierre Gendre; Philippe Seksik; Antoine Blain; Etienne H Metman; Andrée Nisard; Guillaume Cadiot; Michel Veyrac; Benoît Coffin; Xavier Dray; Fabrice Carrat; Philippe Marteau
Journal: Gut Date: 2010-11-29 Impact factor: 23.059

1 in total

1. Inflammatory bowel disease, women, and pregnancy.

Authors: Sunanda V Kane
Journal: Gastroenterol Hepatol (N Y) Date: 2013-11

1 in total

IBD: measuring what counts-safety of IBD medications in pregnancy.

1. Perinatal outcomes in inflammatory bowel disease.

2. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.

3. A controlled double blind study of azathioprine in the management of Crohn's disease.

4. [Prevalence and prenatal diagnosis of congenital malformations in the Parisian population: twenty years of surveillance by the Paris Registry of congenital malformations].

5. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

6. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

7. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.

8. Studies of prostaglandins and sulphasalazine in ulcerative colitis.

9. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.

10. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States.

1. Inflammatory bowel disease, women, and pregnancy.